- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for icgn
If the FDA Can’t Help Ocugen Stock, You Have to Wonder Who Can
Because of the pandemic, OCGN stock attracts speculative interest. But it is not likely to pay off in the long-run
Ocugen Just Overcame a Serious Hurdle
OCGN stock has skyrocketed on positive Phase 3 results. But the company is facing tough competition.
What the WHO Snub Means For Ocugen Stock Investors?
Add the World Health Organization’s suspension of Covaxin to the list of troubles that are weighing down OCGN stock.
Ocugen Stock Is Essentially Back to Being an Eye Disease Play
OCGN stock has a tough path to entry in the North American market and time is not on its side
Is Ocugen Worth a Shot Because of the Worsening Pandemic?
While OCGN stock seems like a reasonable speculation based on the worsening Covid-19 crisis, it’s still a tough gamble.
The Vaccine Deal Boost Can’t Keep Ocugen Stock Afloat
No one wants to be the bearer of bad news, but we must acknowledge that the vertical move in OCGN stock is turning out to…
Ocugen Has a Longer Road To Paying off Than People Think
Ocugen seems to have delivered good news in recent days, yet OCGN stock is right back where it started. Does that create a buying opportunity?
Despite an 80% Drop, Ocugen Stock Is Still Too Pricey
Until the hype surrounding its Covid-19 vaccine candidate is no longer priced into shares, it’s best to avoid OCGN stock.
Biotech Speculators Should Try a Small Position in Ocugen Stock
Probably because it’s not a buzzworthy coronavirus stock, you might not hear much about OCGN stock but it still has strong upside potential.
It’s Time To Drop Ocugen Stock While You Still Can
Hope is one thing, but for investors in OCGN stock expecting regulators or other bulls to come to the rescue is looking less likely
Icon Energy Fund Offers Commodity Focus to IRA Investors
With top oil stocks like Exxon and Chevron, the Icon Energy Fund is a good way to buy the energy sector and the rise in…
OCGN Stock: The COVAXIN News That Has Ocugen Plunging Today
Retail investors refuse to let OCGN stock die, even as the company makes it known that it wouldn’t be applying for a crucial authorization.
The Slide in Ocugen Could Be a Slide to a Homerun
Ocugen has potential for its gene therapy treatment for eye diseases, but OCGN stock movement has been all about Covaxin.
Ocugen Stock Looks Overinflated
Celebrating Ocugen’s value-added collaboration to develop a potentially lifesaving vaccine is fine, but OCGN stock might be too pricey now.
5 Investors Betting Big on Ocugen (OCGN) Stock Right Now
Ocugen has been falling after announcing a new share offering. But that’s not the only reason hedge funds are moving away from OCGN stock.
OCGN Stock: 2 Huge Reasons Ocugen Stock Is Shooting Higher Today
OCGN stock is surging on some big news. The World Health Organization could give the company the go-ahead on its Covid-19 vaccine very soon.
Investor Fears About Covaxin Have Ocugen Shares on Sale
OCGN stock at this point is either an inexpensive Covid-19 vaccine stock, or an over-priced investigational gene therapy stock — or both.
Ocugen Stock Isn’t Pricing In the Hard Road Ahead
OCGN stock has soared thanks to a Covid-19 vaccine partnership. But Ocugen needs time, capital, and competitive success that may not arrive.
OCGN Stock: The Big News Boosting Support for Ocugen Today
Today, OCGN stock is on the move as the company announced a new Senior VP for the company’s manufacturing and supply chain.
Ocugen Stock Is Not One to Trust With Nest Egg Funds
There is too much riding on hope for OCGN stock. It is OK to trade it but fundamental investments are too risky for most.
Make Sure You See Ocugen Stock With Clear Eyes
OCGN stock is a hot trade at this point in 2021. But it’s important for investors to see the company’s outlook clearly.
OCGN Stock: Why Ocugen Shares Are Soaring 130% Today
OCGN stock is on the move Tuesday after Ocugen announced plans to commercialize and develop a Covid-19 vaccine.
OCGN Stock Alert: Why Is Ocugen Soaring 10% Today?
Shares of OCGN stock are in the green after Covaxin demonstrated strong protection against the omicron and delta variants.
9 – 10 of 240 results
